Reduction in tumor lymphocyte infiltration and PD-L1 positivity. Promotion of invasion, EMT, and metastasis via TGF-β, Smad2/3, and PI3K/AKT/GSK-3β pathways. Enhancement of chemoresistance and oxidative stress control through Nrf2 activation. This evidence concerns the gene SMAD2 and neoplasm.